CuraMedix Commits to Exhibit at OTX25
CuraMedix, an emerging leader in the medical technology field focused on regenerative medicine, committed today to join AAOM as an exhibitor at the OTX25 conference in Vancouver, Washington from April 2-5, 2025.
CuraMedix specializes in technology for non-surgical musculoskeletal healthcare, stimulating the repair and regeneration of connective tissue, musculoskeletal, and vascular structures. Extracorporeal Pulse Activation Technology (EPAT), which can be used in combination with biologics and ultrasound-lead technology, can improve physician care and patient results. In many cases, EPAT can be used as an alternative to surgery, allowing the body to heal itself rather than further damaging an area that has degenerated because of poor blood flow, tissue injury, overuse, or weakness.
Orthopedic products include Extracorporeal Pulse Activation Technology (EPAT), Extracorporeal Shockwave Therapy (ESWT), and Extracorporeal Magnetotransduction Therapy (EMTT), which are innovative evidence-based technology platforms used extensively around the world to stimulate tissue repair and regeneration. CuraMedix, the leading US distributor of STORZ Medical devices, offers the complete suite of Radial Pressure Wave, Focused Shockwave, and EMTT devices.
Exhibitor and sponsor registration is open at: https://bit.ly/OTX25-Exhibits.